Kaltura, a US and Israel-based open source video company backed by chip maker Intel’s corporate venturing unit, has raised $25m in its series D round. Japan-based financial services groups Mitsui and Orix’s venture groups led the D round as new investors and to help the portfolio company expand into Asia (Apac). Kenichi Kimura, executive president… Continue reading Kaltura takes shot with $25m
Month: November 2012
RTP plays with MabVax and Datadog
RTP was part of consortia investing $5.25m in MabVax Therapeutics and $6.2m in Datadog.
Roamware joins with Unify
Earlier in the month, Roamware hired Ebrahim Abbasi as its president.
Mail.ru sells Facebook, Groupon, Zynga stakes
The Russia-based internet group sells stakes in the US-based daily deals, gaming and social media companies.
Innovent scoops up $25m
US Pharmaceutical corporation Eli Lilly and financial services provider Fidelity Investments, invested $25m in the expanding Chinese bioscience manufacturer Innovent Biologics.
VuClip secures $13m
The Asia-based mobile video streaming company wins backing of SingTel Innov8.
Advance and Battery settle with Modria
Battery Ventures and Advanced Technology Ventures has taken part in a $1.2m seed funding round for US-based online court resolution search engine Modria.
Genacast helps launch $1.8m at Mortar Data
Comcast-backed Genacast Ventures has led a $1.8m seed round for US-based Mortar Data.
AGTC raises $37.5m
SR One leads the $37.5m B round for the gene therapy company with existing corporate investor MedImmune Ventures also investing.
Cisco acquires Meraki
Cisco snaps up for $1.2bnUS-based cloud infrastructure startup Meraki, which is backed by US-based search engine Google.
The Big Deal: Intractable Intarcia
With such sizeable funding in place, if Intarcia can carry out a successful trial it would be in a stronger position to reap the returns of what could be a blockbuster treatment worth billions of dollars per year as well as a technology potentially applicable in other areas.
Investors insert $210m into Intarcia
Intarcia Therapeutics, a US-based biopharmaceutical firm whose name is derived from the Latin for insert, has nearly doubled the equity it has raised over the past 15 years with its latest $160m round. Intarcia said its combined $160m sale of shares and $50m debt placement was “the largest sum to be raised by a private… Continue reading Investors insert $210m into Intarcia
Powerlist paints portrait of industry
Our forthcoming Powerlist covering the 100 most powerful people in corporate venturing is due for publication on November 26 and makes for a fascinating insight into who are the key decision-makers in this growing industry.
Qualcomm acquires EPOS assets
Qualcomm Technologies has made its third acquisition in Israel, acquiring selected EPOS assets for an undisclosed amount.